Drug details
Fludeoxyglucose F 18 Injection (fdg)
type of Radiopharmaceuticals
Fludeoxyglucose F 18 Injection (fdg) is a positron emitting radiopharmaceutical used for diagnostic purposes in conjunction with Positron Emission Tomography (PET). Fludeoxyglucose F 18 Injection is used to assist assessment of cancer, coronary artery disease, or epileptic seizures.